OSE Immunotherapeutics SA

06/05/2024 | Press release | Distributed by Public on 06/05/2024 01:12

OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant